<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">AMLODIPINE</span><br/>(am-lo'di-peen)<br/><span class="topboxtradename">Norvasc<br/></span><b>Classifications:</b> <span class="classification">cardiovascular agent</span>; <span class="classification">calcium channel blocker</span>; <span class="classification">antihypertensive agent</span><br/><b>Prototype: </b>Nifedipine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>2.5 mg, 5 mg, 10 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Amlodipine is a calcium channel blocking agent that selectively blocks calcium ion reflux across cell membranes of cardiac
         and vascular smooth muscle without changing serum calcium concentrations. It predominantly acts on the peripheral circulation,
         decreasing peripheral vascular resistance, and increases cardiac output.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Amlodipine reduces systolic, diastolic, and mean arterial blood pressure.</p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of mild to moderate hypertension and angina.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to amlodipine; pregnancy (category C).</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Liver disease; concomitant use with hypotension; CHF; lactation; older adults.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Hypertension</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 510 mg once daily<br/><span class="rdage">Geriatric:</span> <span class="rdroute"></span> Start with 2.5 mg, adjust dose at intervals of not less than 2 wk<br/><br/><span class="impairmenttitle">Hepatic Impairment</span><br/>Start with 2.5 mg, adjust dose at intervals of not less than 2 wk<br/><br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give drug without regard to meals.</li>
<li>Prescribed initial dosages of 2.5 mg daily are common if added to a regimen including other antihypertensive drugs.</li>
<li>
            				Note: Doses are usually titrated over a period of 14 d or more rapidly if warranted.
            			
         </li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CV:</span> Palpitations, flushing tachycardia, <span class="speceff-common">peripheral or facial edema</span>, bradycardia, chest pain, syncope, postural hypotension. <span class="typehead">CNS:</span> Light-headedness, fatigue, <span class="speceff-common">headache</span>. <span class="typehead">GI:</span> Abdominal pain, nausea, anorexia, constipation, dyspepsia, dysphagia, diarrhea, flatulence, vomiting. <span class="typehead">Urogenital:</span> Sexual dysfunction, frequency, nocturia. <span class="typehead">Respiratory:</span> Dyspnea. <span class="typehead">Skin:</span> Flushing, rash. <span class="typehead">Other:</span> Arthralgia, cramps, myalgia. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Adenosine</b> may increase the risk of bradycardia; <b>bosentan</b> may decrease efficacy of amlodipine; additive hypotensive effects with other <span class="classification">antihypertensive agents</span>; <span class="classification">azole antifungals</span> (e.g., <b>fluconazole,</b>
<b>itraconazole</b>) may inhibit metabolism of amlodipine; <b>itraconazole</b> may increase edema. <span class="typehead">Food:</span>
<b>Grapefruit juice</b> may increase amlodipine levels. <span class="typehead">Herbal:</span>
<b>Ephedra,</b>
<b>Ma Huang,</b>
<b>melatonin</b> may antagonize antihypertensive effects. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> &gt;90% absorbed from GI tract. <span class="typehead">Onset:</span> Gradual. <span class="typehead">Peak:</span> 69 h. <span class="typehead">Duration:</span> 24 h. <span class="typehead">Distribution:</span> &gt;95% protein bound. <span class="typehead">Metabolism:</span> Extensively metabolized in the liver to inactive metabolites. <span class="typehead">Elimination:</span> Inactive metabolites primarily excreted in urine (Half-Life: 60 y: 40120 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor BP for therapeutic effectiveness. BP reduction is greatest after peak levels of amlodipine are achieved 69 h
            following oral doses.
         </li>
<li>Monitor for S&amp;S of dose-related peripheral or facial edema that may not be accompanied by weight gain; rarely, severe edema
            may cause discontinuation of drug.
         </li>
<li>Monitor BP with postural changes. Report postural hypotension. Monitor more frequently when additional antihypertensives or
            diuretics are added.
         </li>
<li>Monitor heart rate; dose-related palpitations (more common in women) may occur.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report significant swelling of face or extremities.</li>
<li>Take care to have support when standing &amp; walking due to possible dose-related light-headedness/dizziness.</li>
<li>Report shortness of breath, palpitations, irregular heartbeat, nausea, or constipation to physician.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>